DOJ announces Purdue Pharma's plea deal in opioid probe
DOJ announces Purdue Pharma's plea deal in opioid probe

Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that imposed significant penalties exceeding $8 billion, though the lion's share will go largely unpaid.